Can diabetes I and early blindness be prevented using a tylenol combination which inhibits oxidative and nitrosative

Knox Van Dyke1, Erica Ghareeb, Robert Hoeldtke

  • 1Department of Biochemistry and Molecular Pharmacology, Robert C. Byrd Medical Center, West Virginia University Morgantown, WV 26506, USA.

ISRN Toxicology
|June 1, 2013
PubMed

Insights

This study explored preventing diabetes by neutralizing toxins produced by nitric oxide. Antioxidants like carboxy-PTIO, quercetin, and acetaminophen successfully prevented diabetes and its effects in rats.

Area of Science:

  • Biochemistry
  • Endocrinology
  • Toxicology

Background:

  • Oxidative and nitrosative stress are implicated in diabetes development.
  • Streptozotocin induces diabetes by damaging pancreatic beta cells via nitric oxide-derived toxins.
  • These toxins disrupt insulin production and release, leading to hyperglycemia and complications.

Purpose of the Study:

  • To investigate if antioxidant compounds can prevent diabetes induced by streptozotocin.
  • To determine if a combination of antioxidants can neutralize nitric oxide-derived toxins.
  • To assess the long-term efficacy of this intervention in preventing diabetes-related complications.

Main Methods:

  • In vitro experiments to establish the scientific basis of toxin neutralization.
  • In vivo studies using rats administered streptozotocin to induce diabetes.
  • Treatment with a combination of carboxy-PTIO, quercetin, and acetaminophen.

Main Results:

  • The tri-drug combination effectively neutralized nitric oxide-derived toxins in vitro.
  • Streptozotocin-induced diabetes and its deleterious effects, including poor glucose control and cataracts, were completely prevented in rats for one year.
  • In vitro findings provided a scientific rationale for the in vivo results.

Conclusions:

  • Antioxidant intervention can prevent chemically induced diabetes by targeting specific toxins.
  • A combination of carboxy-PTIO, quercetin, and acetaminophen offers a potential strategy for diabetes prevention.
  • Further research may explore this approach for managing or preventing diabetes.

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...